Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open randomized crossover pilot study of sevelamer vs active vitamin D in chronic kidney disease stage 3b
2010-020415-36Phase 2Completed
- Sponsor
- Stavanger University Hospital
- Start
- Jun 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sevelamer carbonate and alfacalcidol in chronic kidney disease (CKD) (2 arms), sponsored by Stavanger University Hospital. Primary endpoint: Plasma FGF23 level. Started Jun 2010; status: completed.
02
Drugs
sevelamer carbonatealfacalcidol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2010-020415-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020415-36.